Bertil Lindmark M.D., Ph.D.
Net Worth
Last updated:
What is Bertil Lindmark M.D., Ph.D. net worth?
The estimated net worth of Prof. Bertil Lindmark M.D., Ph.D. is at least $2,465,811 as of 22 Mar 2022. He owns shares worth $55,291 as insider and has received compensation worth at least $2,410,520 in Galecto, Inc..
What is the salary of Bertil Lindmark M.D., Ph.D.?
Prof. Bertil Lindmark M.D., Ph.D. salary is $602,630 per year as Chief Medical Officer in Galecto, Inc..
How old is Bertil Lindmark M.D., Ph.D.?
Prof. Bertil Lindmark M.D., Ph.D. is 70 years old, born in 1955.
What stocks does Bertil Lindmark M.D., Ph.D. currently own?
As insider, Prof. Bertil Lindmark M.D., Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Galecto, Inc. (GLTO) | Chief Medical Officer | 16,604 | $3.33 | $55,291 |
What does Galecto, Inc. do?
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.
Bertil Lindmark M.D., Ph.D. insider trading
Galecto key executives
Galecto, Inc. executives and other stock owners filed with the SEC:
- Dr. Hans T. Schambye (59) Co-Founder, Pres, Chief Executive Officer & Director
- Mr. Anders Pedersen (65) Chief Operating Officer
- Prof. Bertil Lindmark M.D., Ph.D. (70) Chief Medical Officer